Authors: Curran, WJ Ajani, J Ang, K Bonanni, R Bruner, D Byhardt, R Eisenberg, B Gillin, MT Ginsberg, RJ Greven, K Grignon, D Hammond, E Layne, E McCormick, B Mehta, M Michalski, J Okunieff, P Sandler, H Scarantino, CW Willett, C

Citation: Wj. Curran et al., Radiation Therapy Oncology Group, research plan 2002-2006, INT J RAD O, 51(3), 2001, pp. V

Authors: Rubin, J Ajani, J Schirmer, W Venook, AP Bukowski, R Pommier, R Saltz, L Dandona, P Anthony, L

Citation: J. Rubin et al., Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome, J CL ONCOL, 17(2), 1999, pp. 600-606

Authors: Janjan, NA Abbruzzese, J Pazdur, R Khoo, VS Cleary, K Dubrow, R Ajani, J Rich, TA Goswitz, MS Evetts, PA Allen, PK Lynch, PM Skibber, JM

Citation: Na. Janjan et al., Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer, RADIOTH ONC, 51(2), 1999, pp. 153-160

Authors: Partyka, S Dumas, P Ajani, J

Citation: S. Partyka et al., Combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma, CANCER, 85(11), 1999, pp. 2336-2339

Authors: Kelsen, DP Ginsberg, R Pajak, TF Sheahan, DG Gunderson, L Mortimer, J Estes, N Haller, DG Ajani, J Kocha, W Minsky, BD Roth, JA

Citation: Dp. Kelsen et al., Chemotherapy followed by surgery compared with surgery alone for localizedesophageal cancer, N ENG J MED, 339(27), 1998, pp. 1979-1984